Phát hiện mới giúp điều trị hiệu quả hơn bệnh ung thư phổi
Theo các nhà nghiên cứu Mỹ, họ đã phát hiện một protein được gọi là EMP-1 có trong các khối u ở bệnh nhân ung thư phổi chính là nguyên nhân dẫn đến kháng thuốc Iressa (gefitinib), giúp cho việc điều trị căn bệnh này hiệu quả hơn.
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